Celularity Inc. - Warrant
Celularity Inc. - Warrant
Aktie · US1511901134 · CELUW (XNAS)
Übersicht
Kein Kurs
10.09.2025 20:00
1 Tag
-
1 Woche
-
1 Monat
-
3 Monate
-
6 Monate
-
Jahr bis heute
-
1 Jahr
-
2 Jahre
-
3 Jahre
-
4 Jahre
-
5 Jahre
-
10 Jahre
-
20 Jahre
-
Max
-
Analyst Grade Summary
gauge-img
Kaufen
Starker Kauf
Kaufen
Halten
Verkaufen
Starker Verkauf
0
2
1
1
0
Aktuelle Kurse von Celularity Inc. - Warrant
BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
CELUW
USD
10.09.2025 20:00
0,05 USD
-0,005 USD
-9,62 %
Free Float & Liquidität
Free Float 55,87 %
Shares Float 13,38 M
Ausstehende Aktien 23,95 M
Firmenprofil zu Celularity Inc. - Warrant Aktie
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-001, placental-derived unmodified natural killer (NK) cell that is in Phase I clinical trial to treat acute myeloid leukemia, as well as in Phase I/IIa clinical trial for the treatment of glioblastoma multiforme and COVID-19; CYNK-101, an allogeneic genetically modified NK cell, which is in Phase I clinical trial to treat HER2+ gastric and gastroesophageal cancers; APPL-001, a placenta-derived mesenchymal-like adherent stromal cell that is in a pre-clinical stage for the treatment of Crohn's disease; and PDA-002, a placenta-derived mesenchymal-like adherent stromal cell, which is in pre-clinical stage for the treatment of facioscapulohumeral muscular dystrophy. It also sells and licenses products that are used in surgical and wound care markets, such as Biovance and Interfyl; collects stem cells from umbilical cords and placentas; and provides cells storage under the LifebankUSA brand. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey.

Unternehmensdaten

Name Celularity Inc. - Warrant
Firma Celularity Inc.
Symbol CELUW
Website https://www.celularity.com
Heimatbörse XNAS NASDAQ
ISIN US1511901134
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Robert Joseph Hariri
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,1 T
Adresse 170 Park Avenue, 07932 Florham Park
IPO Datum 2021-07-19

Kennungs-Wechsel

Datum Von Zu
19.07.2021 GXGXW CELUW

Ticker Symbole

Name Symbol
NASDAQ CELUW
Weitere Aktien
Investoren, die Celularity Inc. - Warrant halten, haben auch folgende Aktien im Depot:
OP HOLDCO    FLN 24/29
OP HOLDCO FLN 24/29 Anleihe
RALLYE S.A. 2022
RALLYE S.A. 2022 Anleihe
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025